Texas Oncology

The Woodlands, Texas 77380

1 studies enrolling now · 4 studies all time

What they study most

Low Grade Ovarian Serous Adenocarcinoma, Low Grade Serous Ovarian Cancer, Ovarian Cancer, Platinum-resistant Ovarian Cancer

Studies at this site

• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed
• A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation — Running, not enrolling
• Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) — Completed